You are subscribed to the Ophthalmology Times eNews.

ASCRS 2015
Twitter Facebook

View Online  |  Download Magazine  |  Share With A Colleague  |  Print & Digital Subscribe  |  eNewsletter Subscribe

Monday — April 20, 2015

TOP STORIES

Femto safety not guaranteed by adequate suction

In the first study to directly compare two femtosecond lasers for cataract surgery, both were considered safe and efficacious—but surgeons should be alert to eyes that move while under the docking station, said Seth M. Pantanelli, MD, MS. » Find out why

ADVERTISEMENT

"Vision Associates was just the spark my dispensary needed."

"Vision Associates custom built and installed a turnkey program that helped steer me in the right direction and dramatically increased our profits." Dr. John Meyer- Partner, The EyeCare Institute, Louisville, KY. ASCRS Booth #2311
More

Range of 'uninterrupted vision' possible with inlay

Study patients with a near vision inlay implanted under a femtosecond flap achieved extended depth of focus that ranged from +1 to +3 D, said John A. Hovanesian, MD.
» Find out why

Treating dry eye with intense pulsed light

Patients with evaporative dry eye produce an abnormal meibum that is more viscous than patients with normal meibum, said Gargi K. Vora, MD. » Find out why

Re-esterfied omega-3 fatty acids effective for dry eye

Oral consumption of re-esterfied omega-3 fatty acids once daily for 12 weeks is "an effective treatment for dry eye disease," said Eric D. Donnenfeld, MD. » Read why

TearLab @TearLab

So glad you enjoyed it, Dr. Jung! RT @liangsjung: Great meeting, great race, great pals! #ASCRSASOA2015 #runforsight

Wills Eye Hospital @Wills_Eye

Alessandra Intili, MD Summarizes her paper on Femtosecond laser in resident cataract surgery. #ASCRSASOA2015
https://youtu.be/XkFwBaODKQE

Malosa Medical @MalosaMedical

Zeiss seeks FDA approval of SMILE procedure for astigmatic myopia http://ift.tt/1Q6UHst #ASCRSASOA2015

Top Tweets

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

UBM Advanstar Eyecare Group

mdlugoss@advanstar.com

DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logoUBM Advanstar logo